There were 871 press releases posted in the last 24 hours and 190,503 in the last 365 days.


Please use this form to send email to PR contact of this press release:
InterveXion Announces Positive Data in Phase 2 Study of IXT-m200 in Participants with Methamphetamine Use Disorder

Misty Stevens
InterveXion Therapeutics


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image